Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Market Cap	15.46B
Revenue (ttm)	2.35B
Net Income (ttm)	-1.01M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	0.18 (1.36%)
Ex-Dividend Date	Jun 28, 2024

Volume	3,717,530
Average Volume	4,420,853
Open	13.40
Previous Close	13.22
Day's Range	13.16 - 14.34
52-Week Range	6.31 - 16.28
Beta	0.66
RSI	62.63
Earnings Date	Mar 29, 2025

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I cli...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,510
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6127

Financial Performance

In 2023, HKG:6127's revenue was 2.38 billion, an increase of 4.78% compared to the previous year's 2.27 billion. Earnings were 396.99 million, a decrease of -63.04%.

Financial numbers in CNY